Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Predicting development of dementia in the elderly with the Selective Reminding Test.

Masur DM, Fuld PA, Blau AD, Crystal H, Aronson MK.

J Clin Exp Neuropsychol. 1990 Aug;12(4):529-38.

PMID:
2211975
2.

Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data.

Fuld PA, Masur DM, Blau AD, Crystal H, Aronson MK.

J Clin Exp Neuropsychol. 1990 Aug;12(4):520-8.

PMID:
2211974
3.

Distinguishing normal and demented elderly with the selective reminding test.

Masur DM, Fuld PA, Blau AD, Thal LJ, Levin HS, Aronson MK.

J Clin Exp Neuropsychol. 1989 Oct;11(5):615-30.

PMID:
2808653
4.

Development of dementing illnesses in an 80-year-old volunteer cohort.

Katzman R, Aronson M, Fuld P, Kawas C, Brown T, Morgenstern H, Frishman W, Gidez L, Eder H, Ooi WL.

Ann Neurol. 1989 Apr;25(4):317-24.

5.

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease.

Thal LJ, Masur DM, Blau AD, Fuld PA, Klauber MR.

J Am Geriatr Soc. 1989 Jan;37(1):42-8. Review.

PMID:
2642499
6.

Cross-cultural and multi-ethnic dementia evaluation by mental status and memory testing.

Fuld PA, Muramoto O, Blau A, Westbrook L, Katzman R.

Cortex. 1988 Dec;24(4):511-9.

PMID:
3219866
7.

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease.

Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L.

Neurology. 1988 Nov;38(11):1682-7.

PMID:
3185902
8.

Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease.

Katzman R, Brown T, Thal LJ, Fuld PA, Aronson M, Butters N, Klauber MR, Wiederholt W, Pay M, Xiong RB, et al.

Ann Neurol. 1988 Sep;24(3):384-9.

PMID:
3228273
9.

Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH.

Am J Pathol. 1988 Jul;132(1):86-101.

10.

Cognitive impairment and sensory loss associated with chronic low-level ethylene oxide exposure.

Crystal HA, Schaumburg HH, Grober E, Fuld PA, Lipton RB.

Neurology. 1988 Apr;38(4):567-9.

PMID:
3352912
11.

Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A.

Ann Neurol. 1988 Feb;23(2):138-44.

PMID:
2897823
12.

Primitive plaques and memory dysfunction in normal and impaired elderly persons.

Fuld PA, Dickson D, Crystal H, Aronson MK.

N Engl J Med. 1987 Mar 19;316(12):756. No abstract available.

PMID:
3821820
13.

Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease.

Thal LJ, Masur DM, Sharpless NS, Fuld PA, Davies P.

Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):627-36.

PMID:
3797688
14.

Significance of neurotransmitter abnormalities in Alzheimer's disease.

Katzman R, Brown T, Fuld P, Thal L, Davies P, Terry R.

Res Publ Assoc Res Nerv Ment Dis. 1986;64:279-86. No abstract available.

PMID:
2873637
15.

Impaired ranking of semantic attributes in dementia.

Grober E, Buschke H, Kawas C, Fuld P.

Brain Lang. 1985 Nov;26(2):276-86.

PMID:
4084766
16.

Progressive dementia, visual deficits, amyotrophy, and microinfarcts.

Kaplan JG, Katzman R, Horoupian DS, Fuld PA, Mayeux R, Hays AP.

Neurology. 1985 Jun;35(6):789-96.

PMID:
4000480
17.

Test profile of cholinergic dysfunction and of Alzheimer-type dementia.

Fuld PA.

J Clin Neuropsychol. 1984 Nov;6(4):380-92.

PMID:
6094616
18.

Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies.

Horoupian DS, Thal L, Katzman R, Terry RD, Davies P, Hirano A, DeTeresa R, Fuld PA, Petito C, Blass J, et al.

Ann Neurol. 1984 Sep;16(3):305-13.

PMID:
6148912
19.

Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H.

Am J Psychiatry. 1983 Jun;140(6):734-9.

PMID:
6846631
20.

Oral physostigmine and lecithin improve memory in Alzheimer disease.

Thal LJ, Fuld PA, Masur DM, Sharpless NS.

Ann Neurol. 1983 May;13(5):491-6.

PMID:
6347034
21.

Oral physostigmine and lecithin improve memory in Alzheimer's disease.

Thal LJ, Fuld PA, Masur DM, Sharpless NS, Davies P.

Psychopharmacol Bull. 1983;19(3):454-6. No abstract available.

PMID:
6635124
22.

Intrusions as a sign of Alzheimer dementia: chemical and pathological verification.

Fuld PA, Katzman R, Davies P, Terry RD.

Ann Neurol. 1982 Feb;11(2):155-9.

PMID:
7073248
23.
24.

Pathological verification of ischemic score in differentiation of dementias.

Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A.

Ann Neurol. 1980 May;7(5):486-8.

PMID:
7396427
25.

Recovery of intellectual ability after closed head-injury.

Fuld PA, Fisher P.

Dev Med Child Neurol. 1977 Aug;19(4):495-502.

PMID:
892246
26.

Letter: Prevalence and malignancy of Alzheimer disease.

Lijtmaer H, Fuld PA, Katzman R.

Arch Neurol. 1976 Apr;33(4):304. No abstract available.

PMID:
1259648
27.

Storage, retention, and retrieval in Korsakoff's syndrome.

Fuld PA.

Neuropsychologia. 1976;14(2):225-36. No abstract available.

PMID:
934456
28.

Evaluating storage, retention, and retrieval in disordered memory and learning.

Buschke H, Fuld PA.

Neurology. 1974 Nov;24(11):1019-25. No abstract available.

PMID:
4473151

Supplemental Content

Support Center